B is adjudged to be one of the most infectious diseases in the world and a major
public health problem with about 5% of the world population as asymptomatic carriers
translating to 350 million people harboring hepatitis B virus (HBV) globally. Chronic
infection with HBV occurs in up to 90% of infants infected at birth, 30% for children
aged one year to five years, and 6% from six years and above. Thus, prevention of perinatal
infection is an important strategy to reducing the prevalence of chronic hepatitis
B infection in Nigeria being an endemic country. Emphasis therefore is placed on
the screening of all pregnant women for HBsAg during the antenatal visit so as to
detect positive women whose new borne will need prophylaxis to reduce the risk of
contracting the infection.
Objectives: 1. to determine
the percentage of pregnant women who were screened for Hepatitis B at PHC Karu,
Abuja in 2013.2. To determine the sero-prevalence
of Hepatitis B among pregnant women screened at PHC Karu, Abuja, in 2013.3.
To determine whether the policy of prophylaxis against
peri-natal infection for neonates of sero-positive mothers were strictly followed
at this PHC during the review period.
Methods: This is
a retrospective cross-sectional study which used secondary data extracted from antenatal
registers, laboratory registers, HBsAg-positive patients’ antenatal and delivery
case notes for the period under review – Jan.-Dec. 2013.
Results: All the 856
pregnant women who registered for ANC in this PHC were offered HBsAg screening,
99.3% (850) complied with the screening, and 8.5% (72) sero-prevalence recorded.
All the positive cases were referred to secondary health facility for HBIG prophylaxis;
however no follow-up was done to ascertain the outcome.
Conclusion: The high
endemic rate of HBV infection,
(8.5% prevalence) requires more effort at preventing
the vertical transmission. 100% screening rate for all ANC clients is highly encouraged
as well as 100% follow up rate for exposed infants’ HBIG prophylaxis.
HBV infection, pregnant women, Primary Healthcare Centre, HBsAg screening.
. Abdulsalami N., Tekena
O. H., Sergei O. V, Germano M. R., Bernard B. A., Vitaly A. A. (1986) Prevalence
of hepatitis B infection markers in representative areas of Nigeria. Intrn J Epiderm
. Aminu M.,Okachi E.E.,Abubarka S.M.,Yahaya
A. Prevalence of hepatitis B virus surface antigen among asymptomatic students in
a Nigerian University. Ann Afr Med [serial online] 2013 [cited 2014 Apr 4]; 12:55-6.
. Azubike J.C.,N kanginieme K.E.O. (1999).
Paeditrics and child heath in a tropical region. Owerri Nigeria, African educational
. CDC (2016). Viral hepatitis-hepatitis
b, perinatal transmission, updated October, 2016. Accessed from: https://www.cdc.gov/hepatitis/hbv/perinatalxmtn.htm
. Collier J., Longmore M., Scally P. (2003).
Oxford handbook of clinical specialties, 6th Ed. New Delhi, Oxford university press. Pp:
. Emechebe G O, Emodi I J, Ikefuna A N,
Ilechukwu G C, Igwe W C, Ejiofor O S, Ilechukwu C A. Hepatitis B virus infection
in Nigeria - A review. Niger Med J [serial online] 2009 [cited 2014 Apr 4];50:18-22.
Available from: http://www.nigeriamedj.com/text.asp?2009/50/1/18/71932
. Lin K, Vickery J. Screening for Hepatitis
B Virus Infection in Pregnant Women: Evidence for the U.S. Preventive Services Task
Force Reaffirmation Recommendation Statement. AHRQ Publication No. 09-05134-EF-3,
. Lucas A.O.,Gilles H.M. (2003) Short textbook
of public health medicine for the tropics, 4th ed. London, Hodder Arnold. Pp:57-58
. Park K. (2007) Park’s textbook of preventive
and social medicine, 19th Ed.
Jabalpur India, Bhanot publishers Pp:175-179
. Longmore M.,Wilkinson I.,Torok E. (2001).
Oxford handbook of clinical medicine, 5th Ed. New York, Oxford university press. Pp:578-579
. Shiraki K. (2000). Perinatal transmission
of hepatitis B virus and its prevention. Journal of Gastroenterology/Hepatology, Suppl:E11-5.Accessed :.
. World Health Organization (2014). Global
alert response: Hepatitis B. Available from http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index2.html,
accessed on 04/04/2014.
. World Health Organization (2015). Guidelines
for the Prevention, Care and Treatment of Persons with chronic Hepatitis B infection.
p46. Accessed from:
. World Health Organization (2016). Hepatitis Fact sheet, updated July 2016. Accessed from: http://www.who.int/mediacentre/factsheets/fs204/en/
. Zampino R., Boemio A., Sagnelli C.,
Alessio L., Adinolfi L.E., Sagnelli E., and Coppola N. (2015). Hepatitis B virus burden in developing
countries. World Journal of Gastroenterology, 21(42): 11941–11953. Accessed from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641116